Choose your Location, Investor Type and Cookie Preferences
Changing Solvency regulations in the UK and Europe are prompting a reassessment of senior securitised credit, opening the door to opportunities that many insurers have overlooked since the financial crisis.
The retreat of insurers from securitisation in the years following the financial crisis owed as much to regulation as it did to market sentiment, with capital treatment and operational requirements often proving difficult to justify against competing fixed income assets. As reforms in both the UK and European Union (EU) place greater emphasis on the characteristics of underlying risk, the asset class may be moving towards a more constructive footing within institutional portfolios.
Although the two jurisdictions are taking different routes, the direction of travel is broadly similar. Solvency UK reforms are seeking to make securitisation more practical for institutional investors, while changes to Solvency II in the EU promise more risk appropriate capital treatment for senior exposures. Together, these developments are beginning to address the operational and capital barriers that have kept securitised credit at the margins insurer portfolios.
Solvency UK reforms are seeking to make securitisation more practical for institutional investors, while changes to Solvency II in the EU promise more risk appropriate capital treatment for senior exposures.
The implications could be significant because UK and European insurers remain notably underweight securitised credit relative to their US peers, despite many of the portfolio characteristics aligning closely with insurer objectives. The gap suggests that historical allocation patterns may say as much about the difficulty of implementation as they do about investment fundamentals, raising the prospect that changing regulation could unlock previously constrained demand while supporting deeper and more liquid UK and European markets.
The most compelling part of the opportunity lies at the senior end of the capital structure, particularly in high quality collateralised loan obligations (CLOs) alongside selected residential mortgage-backed (RMBS), asset-backed (ABS) and commercial mortgage-backed securities (CMBS). Although these markets are backed by different forms of collateral, senior exposures can combine diversified pools of underlying assets with structural protections designed to absorb stress before losses reach investors at the top of the capital structure.
The implications could be significant because UK and European insurers remain notably underweight securitised credit relative to their US peers, despite many of the portfolio characteristics aligning closely with insurer objectives.
As regulatory treatment becomes more sensitive to those distinctions, the relationship between spread, risk and capital consumption begins to look different. For insurers seeking resilient income, greater diversification and less reliance on unsecured corporate credit, this could make senior securitisation increasingly difficult to overlook, although the relevance and timing of the opportunity will vary between internal model investors and those operating under standard regulatory formulas.
Realising that potential will still require careful implementation, with collateral analysis, structural assessment, ongoing monitoring and manager oversight remaining central to any allocation. Delegation can reduce the operational burden, but it cannot replace robust governance or the specialist expertise needed to navigate a market in which selectivity matters.
Our full paper, Senior securitisations for UK and European insurers: From capital penalty to portfolio opportunity, delves into how regulatory reform is altering the outlook for senior securitisations and their role in insurer portfolios.
The views expressed on this webpage should not be taken as a recommendation, advice or forecast.
The value of investments will fluctuate, which will cause prices to fall as well as rise and you may not get back the original amount you invested. Past performance is not a guide to future performance.